These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36948565)

  • 1. Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia.
    Taher AT; Musallam KM; Viprakasit V; Kattamis A; Lord-Bessen J; Yucel A; Guo S; Pelligra C; Shields AL; Shetty JK; Miteva D; Bueno LM; Cappellini MD
    BMJ Open; 2023 Mar; 13(3):e066683. PubMed ID: 36948565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO
    Taher A; Cappellini MD; Viprakasit V; Sutcharitchan P; Mahmoud D; Laadem A; Khan A; Gwaltney C; Harding G; Attie K; Zhang X; Zou J; Pariseau J; Henry Hu X; Kattamis A
    Am J Hematol; 2019 Feb; 94(2):177-183. PubMed ID: 30394570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
    Taher AT; Cappellini MD; Kattamis A; Voskaridou E; Perrotta S; Piga AG; Filosa A; Porter JB; Coates TD; Forni GL; Thompson AA; Tartaglione I; Musallam KM; Backstrom JT; Esposito O; Giuseppi AC; Kuo WL; Miteva D; Lord-Bessen J; Yucel A; Zinger T; Shetty JK; Viprakasit V;
    Lancet Haematol; 2022 Oct; 9(10):e733-e744. PubMed ID: 36007538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.
    Revicki DA; Rentz AM; Luo MP; Wong RL
    Health Qual Life Outcomes; 2011 May; 9():36. PubMed ID: 21600054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
    Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
    J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.
    Signorovitch J; Brainsky A; Grotzinger KM
    Qual Life Res; 2011 Dec; 20(10):1737-44. PubMed ID: 21533818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
    Burden AD; Bissonnette R; Anatchkova M; Budhiarso I; Skalicky AM; Liberato ACS; Hu N; Thoma C; Gloede T; Kohlmann T; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1383-1390. PubMed ID: 38334243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.
    Finkelstein FO; van Nooten F; Wiklund I; Trundell D; Cella D
    Health Qual Life Outcomes; 2018 May; 16(1):111. PubMed ID: 29855366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
    Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
    J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
    Klonizakis P; Klaassen R; Sousos N; Liakos A; Tsapas A; Vlachaki E
    Ann Hematol; 2017 Nov; 96(11):1937-1944. PubMed ID: 28884221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients.
    Al Maqbali M; Hughes C; Gracey J; Rankin J; Hacker E; Dunwoody L
    J Pain Symptom Manage; 2020 Jan; 59(1):130-138.e2. PubMed ID: 31647976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
    Speck RM; Shalhoub H; Wyrwich KW; Yu R; Ayer DW; Ford J; Bush EN; Lipton RB
    Headache; 2019 May; 59(5):756-774. PubMed ID: 30861580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
    Speck RM; Yu R; Ford JH; Ayer DW; Bhandari R; Wyrwich KW
    Headache; 2021 Mar; 61(3):511-526. PubMed ID: 33481276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials.
    Bartlett SJ; Bingham CO; van Vollenhoven R; Murray C; Gruben D; Gold DA; Cella D
    Arthritis Res Ther; 2022 Apr; 24(1):83. PubMed ID: 35382883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).
    Kawata AK; Hareendran A; Shaffer S; Mannix S; Thach A; Desai P; Mikol DD; Ortmeier B; Bayliss M; Buse DC
    Headache; 2019 Sep; 59(8):1253-1269. PubMed ID: 31168803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Fatigue in Patients Receiving Kidney Replacement Therapy Using PROMIS Computer Adaptive Testing.
    Dano S; Hussain J; Edwards N; Sun YI; Li M; Howell D; Peipert JD; Novak M; Bartlett SJ; Mucsi I
    Am J Kidney Dis; 2023 Jul; 82(1):33-42.e1. PubMed ID: 36906218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.